Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.
Method Article
In this report, we demonstrate a system to isolate and culture donor cells from the mouse mammary gland, and orthotopically transplant these cells in recipient mice to analyze stromal: epithelial interactions during mammary tumor development.
The influence of stromal cells, including fibroblasts on mammary tumor progression has been well documented through the use of mouse models, in particular through transplantation of stromal cells and epithelial cells in the mammary gland of mice. Current transplantation models often involve the use of immunocompromised mice due to the different genetic backgrounds of stromal cells and epithelial cells. Extracellular matrices are often used to embed the two different cell types for consistent cell-cell interactions, but involve the use of Matrigel or rat tail collagen, which are immunogenic substrates. The lack of functional T cells from immunocompromised mice prevents accurate assessment of stromal cells on mammary tumor progression in vivo, with important implications on drug development and efficacy. Moreover, immunocompromised mice are costly, hard to breed and require special care conditions. To overcome these obstacles, we have developed an approach to orthotopically transplant stromal cell and epithelial cells into mice from the same genetic background to induce consistent tumor formation. This system involves harvesting normal, carcinoma associated fibroblasts, PyVmT mammary carcinoma cells and collagen from donor C57BL/6J mice. The cells are then embedded in collagen and transplanted in the inguinal mammary glands of female C57BL/6J mice. Transplantation of PyVmT cells alone form palpable tumors 30-40 days post transplantation. Endpoint analysis at 60 days indicates that co-transplantation with fibroblasts enhances mammary tumor growth compared to PyVmT cells transplanted alone. While cells and matrix from C57BL/6J mice were used in these studies, the isolation of cells and matrix and transplantation approach may be applied towards mice from different genetic backgrounds demonstrating versatility. In summary, this system may be used to investigate molecular interactions between stromal cells and epithelial cells, and overcomes critical limitations in immunocompromised mouse models.
1. Isolation and extraction of donor collagen from C57BL/6J mice
2. Isolation and culture of donor mammary carcinoma cells and fibroblasts from normal and PyVmT C57BL/6J mice
3. Immunofluorescence staining of cultured cells
4. Preparation of collagen embedded cells for grafting
5. Orthoptic transplantation of collagen embedded cells in C57BL/6J mice
6. Representative Results:
Isolation and extraction of collagen from C57BL/6J mice
These procedures were adapted from1. Extraction of collagen protein from 5-7 mouse tails yields approximately 1-1.5 mg/ml in a 6 ml final volume, or 6- 9 mg of protein. By coommassie stain, bands corresponding to 90 kda and 130 kda are detected in the lanes loaded with samples extracted from mouse tails, indicating the presence of collagen type I and pro-collagen respectively (Figure 1).
Isolation and culture of mammary carcinoma cells and fibroblasts from normal and PyVmT C57BL/6J mice.
The procedures were adapted from2. PyVmT carcinoma cells and fibroblasts can be distinguished by differences in cell morphology and expression of specific epithelial and mesenchymal markers. PyVmT carcinoma cells are identified by cobblestone shape and co-express CK18, a luminal epithelial marker and CK14, a basal epithelial marker, but not express α-sma (Figure 2). Mammary fibroblasts are larger cells with a spindle shaped phenotype and express high levels of α-sma but do not express CK14 or CK 18 (Figure 2). These data indicate over 95% cell purity for fibroblasts and epithelial cells using the outlined procedures.
Orthoptic transplantation of collagen embedded cells in C57BL/6J mice
These procedures were adapted from3, 4. Transplantation recipient mice are sacrificed when tumors in either experimental group reach 1.0 cm in diameter, or approximately 60 days. While transplantation of PyVmT cells alone results in palpable tumors after 30- 40 days, reaching a mean tumor mass of 0.335 grams at 60 days, co-transplantation of PyVmT carcinoma cells with mammary fibroblasts results in a mean tumor mass of 0.630 grams, indicating enhancement of tumor growth by fibroblasts (Figure 3).
Figure 1. Coomassie stain analysis of collagen type I extraction from mouse tails. BSA (˜ 66 kda) is indicated by arrow. Commercial rat tail collagen (20 μg protein), and purified mouse tail collagen (20 μg protein) are indicated by box (˜130 kda, ˜ 90 kda proteins). Std= molecular weight standard.
Figure 2. Immunofluorescence staining of donor PyVmT mammary carcinoma cells and fibroblasts. Panels a and b represent PyVmT mammary carcinoma cells immunostained for antibodies to CK14 and CK18. Panel c represents fibroblasts stained with antibodies to α-sma. Images shown with DAPI overlay at 20x magnification.
Figure 3. Mammary tumor development in C57BL/6J mice in the presence or absence of fibroblasts. Mammary tumors were harvested from mice transplanted with PyVmT carcinoma cells in the presence or absence of mammary fibroblasts and weighed. Mean+standard error of the mean. N=6 per group.
The functional contribution of fibroblasts in tumor progression has been demonstrated through transplantation models, in which carcinoma associated fibroblasts co-transplanted with benign mammary epithelial cells results in increased tumor growth and invasiveness5. Conventional transplantation approaches have involved the use of SCID or nude mice to co-transplant stromal and epithelial cells from different genetic mouse backgrounds or different species. Immunocompromised mice lack functional T cells, which pl...
Animal experiments:
Experiments on animals were performed in accordance with the guidelines and regulations set forth by the IACUC committee at the University of Kansas Medical Center.
This project was funded through by NIH/NCI grant number R00 CA127357 and University of Kansas Cancer Center Endowment.
Name | Company | Catalog Number | Comments |
C57BL/6N mice | Harlan Laboratories | N/A | |
MMTV-PyVmT transgenic mice | Jackson Laboratory | 002374 | |
Fetal Bovine Serum | Fisher Scientific | SH3039603PR | |
DMEM | VWR international | 10000113873 | |
Penicillin/streptomycin | Fisher Scientific | MT-30-001 | |
amphotericin | Fisher Scientific | BP2645-20 | |
Amicon filtration columns ultracel 50k | EMD Millipore | UFC905008 | |
Tubes for Beckman TI rotor | Beckman Coulter Inc. | 355618 | |
Rat tail collagen | Fisher Scientific | CB 40236 | |
10x EBSS | Sigma-Aldrich | E7510-100ML | |
Trypsin 1X, 0.25% in HBSS w/o Calcium and Magnesium | Fisher Scientific | MT-25-050-CI | |
Glacial acetic acid | Fisher Scientific | A491-212 | |
Coomasie blue | Fisher Scientific | BP101 25 | |
Trypsin | Sigma-Aldrich | T3924-100ml | |
Collagenase A | Sigma-Aldrich | ||
hyalronidase | Sigma-Aldrich | H3884 | |
DNase | Sigma-Aldrich | D5025 | |
Kaleidoscope Protein standard | Bio-Rad | 1610375 | |
Glass slides | Fisher Scientific | 12545-78 | |
Glass coverslips | VWR international | 101400-042 | |
Vimentin antibody S-20 | Santa Cruz Biotechnology, Inc. | SC-7558 | |
α-smooth muscle actin antibody | Abcam | ab5694 | |
CK14 antibody | Santa Cruz Biotechnology, Inc. | sc-53253 | |
CK18 antibody | Abcam | ab668 | |
DAPI | Sigma-Aldrich | D9542 | |
Anti-mouse biotinylated | Vector Laboratories | BA9200 | Distributed through Fisher |
Anti-mouse-alexa-568 | Invitrogen | A10037 | |
Anti-mouse- alexa-488 | Invitrogen | A11001 | |
Streptavidin- alexa-488 | Invitrogen | S11226 | |
DAPI | Invitrogen | D21490 | |
Prolong antifade | Invitrogen | P-36930 | |
Surgical scissors | Fine Science Tools | 91400-12 | |
Fine spring scissors | Fine Science Tools | 15000-02 | |
Blunt forceps | Fine Science Tools | 11002-12 | |
# 5 fine forceps | Fine Science Tools | 11251-10 | |
Gut chromic suture | Fisher Scientific | NC9326254 | |
Glass Pasteur pipet | Fisher Scientific | 22-042-815 | |
Ethanol | Fisher Scientific | A406P 4 | |
betadine | Fisher Scientific | NC9386574 | |
Wound clips | Fisher Scientific | 12032-07 | |
Wound staple | Fisher Scientific | 12031-07 |
Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE
Zapytaj o uprawnieniaThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone